🍁Based in Canada. Fully manufactured in Canada.

CJC-1295 + Ipamorelin 20 mg

🇨🇦 Canadian First Lyfe is the first manufacturer of dual chamber pens in Canada. Learn More →

Description

A blend of CJC-1295, a growth-hormone-releasing hormone (GHRH) analog, and Ipamorelin, a selective ghrelin-receptor agonist. The two act on complementary pathways and are frequently paired in secretagogue research.

Commonly explored in research for:

  • Synergistic growth-hormone release from two mechanisms
  • Pulsatile GH secretion and IGF-1 axis models
  • Ghrelin-receptor (GHS-R) and GHRH-receptor signalling
  • Body-composition and metabolic research models

Supplied as 20 mg lyophilized powder; also available loaded in the Lyfe pen.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 + Ipamorelin 20 mg”

Your email address will not be published. Required fields are marked *